Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT00167856
Eligibility Criteria:
Inclusion Criteria:
* participant must be able to swallow pills
* fluent in English
* incomplete or complete spinal cord injury
* presence of at least moderately severe neuropathic pain at or below the level of injury
* spinal cord injury at least 2 year prior to entering the study
* pain for at least 6 months prior to entering the study
* spinal cord injury level above L1
* participants on anticonvulsants are considered
* approval of primary physician
Exclusion Criteria:
* pregnant women, or those contemplating pregnancy
* prior history of use of Venlafaxine hydrochloride (Effexor)
* current use of MAOI medications
* persons who have a recent (past year) history of alcohol or drug abuse
* persons with a history of renal disease, heart disease or uncontrolled hypertension, liver disease or hepatic cirrhosis, active major medical or psychiatric illness
* persons with a significant post-traumatic encephalopathy from head trauma sustained at SCI
* persons with tardive dyskinesia or narrow angle glaucoma
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00167856
Study Brief:
Protocol Section:
NCT00167856